Refine
Year of publication
Language
- English (111)
Has Fulltext
- yes (111)
Is part of the Bibliography
- no (111)
Keywords
- Diffraction (3)
- Elastic scattering (3)
- Collectivity (2)
- Correlation (2)
- Polarization (2)
- RHIC (2)
- Shear viscosity (2)
- ATAD2 (1)
- B-slope (1)
- BRD2 (1)
Institute
- Physik (64)
- Frankfurt Institute for Advanced Studies (FIAS) (41)
- Medizin (4)
- Biowissenschaften (1)
- Geowissenschaften / Geographie (1)
- Informatik (1)
- Pharmazie (1)
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
(2017)
Global changes in chromatin accessibility may drive cancer progression by reprogramming transcription factor (TF) binding. In addition, histone acetylation readers such as bromodomain-containing protein 4 (BRD4) have been shown to associate with these TFs and contribute to aggressive cancers including prostate cancer (PC). Here, we show that chromatin accessibility defines castration-resistant prostate cancer (CRPC). We show that the deregulation of androgen receptor (AR) expression is a driver of chromatin relaxation and that AR/androgen-regulated bromodomain-containing proteins (BRDs) mediate this effect. We also report that BRDs are overexpressed in CRPCs and that ATAD2 and BRD2 have prognostic value. Finally, we developed gene stratification signature (BROMO-10) for bromodomain response and PC prognostication, to inform current and future trials with drugs targeting these processes. Our findings provide a compelling rational for combination therapy targeting bromodomains in selected patients in which BRD-mediated TF binding is enhanced or modified as cancer progresses.